|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS: | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Restricted cash and cash equivalents | ||||||||||||||||||||
| Debt Securities, Available-for-sale, Restricted | ||||||||||||||||||||
| Loans receivable | ||||||||||||||||||||
| Allowance for credit losses | ||||||||||||||||||||
| Loans receivable, net | ||||||||||||||||||||
| Property and equipment, net | ||||||||||||||||||||
| Income taxes receivable | ||||||||||||||||||||
| Other assets | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| LIABILITIES AND SHAREHOLDERS’ EQUITY: | ||||||||||||||||||||
| Liabilities: | ||||||||||||||||||||
| Accounts payable and accrued liabilities | ||||||||||||||||||||
| Revolving secured lines of credit | ||||||||||||||||||||
| Secured financing | ||||||||||||||||||||
| Senior notes | ||||||||||||||||||||
| Other Borrowings | ||||||||||||||||||||
| Deferred income taxes, net | ||||||||||||||||||||
| Income taxes payable | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Shareholders' Equity: | ||||||||||||||||||||
| Preferred stock, $.01 par value, 1,000,000 shares authorized, none issued | ||||||||||||||||||||
| Common stock, $.01 par value, 80,000,000 shares authorized, 10,376,049 and 10,680,143 shares issued and outstanding as of June 30, 2026 and December 31, 2025, respectively | ||||||||||||||||||||
| Paid-in capital | ||||||||||||||||||||
| Retained earnings | ||||||||||||||||||||
| Accumulated other comprehensive income (loss) | ||||||||||||||||||||
| Total shareholders’ equity | ||||||||||||||||||||
| Total liabilities and shareholders’ equity | ||||||||||||||||||||
| Preferred stock, par value (in usd per share) | ||||||||||||||||||||
| Preferred stock, shares authorized | ||||||||||||||||||||
| Preferred stock, shares issued | ||||||||||||||||||||
| Common stock, par value (in usd per share) | ||||||||||||||||||||
| Common stock, shares authorized | ||||||||||||||||||||
| Common stock, shares issued | ||||||||||||||||||||
| Balance, shares |
Loading...
